Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence-Reference-Cited by-同舟云学术

Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence

Published:2022-11-17 Issue:11 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wagner Carina¹,Griesel Mirko²,Mikolajewska Agata³,Metzendorf Maria-Inti⁴,Fischer Anna-Lena²,Stegemann Miriam³,Spagl Manuel²,Nair Avinash Anil⁵,Daniel Jefferson⁶,Fichtner Falk²,Skoetz Nicole¹

Affiliation:

1. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

2. Department of Anaesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany

3. Department of Infectious Diseases and Respiratory Medicine; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Berlin Germany

4. Cochrane Metabolic and Endocrine Disorders Group; Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf; Düsseldorf Germany

5. Department of Respiratory Medicine; Christian Medical College; Vellore India

6. Department of Pulmonary Medicine; Christian Medical College; Vellore India

Publisher

Wiley

Subject

Pharmacology (medical)

Reference242 articles.

1. The randomised embedded multifactorial adaptive platform for community-acquired pneumonia (REMAP-CAP) study: rationale and design;Angus;Annals of the American Thoracic Society,2020

2. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomised clinical trial;Angus;JAMA,2020

3. Methylprednisolone in adults hospitalised with COVID-19 pneumonia: an open-label randomised trial (GLUCOCOVID);Corral-Gudino;Wiener Klinische Wochenschrift,2021

4. Corral L Bahamonde A Arnaiz delas Revillas F Gomez-Barquero J Abadia-Otero J Garcia-Ibarbia C GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalised with COVID-19 pneumonia medRxiv [Preprint] 10.1101/2020.06.17.20133579

5. Dequin PF Gouge AL Tavernier E Giraudeau B Zohar S Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience Statistics in Biopharmaceutical Research 2020 1 5 https://www.embase.com/search/results?subaction=viewrecord&id=L2005906375&from=export

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normalization of IL-6 levels is associated with survival in critically ill patients with COVID-19;Journal of Critical Care;2024-12

2. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action;Heliyon;2024-08

3. Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial;BMC Infectious Diseases;2024-07-22

4. Intensive care unit-acquired infections more common in patients with COVID-19 than with influenza;Scientific Reports;2024-07-19

5. Clinical efficacy of various regimens of systemic glucocorticoids therapy in COVID-19 patients;Meditsinskiy sovet = Medical Council;2024-05-10